SAN FRANCISCO, Dec. 26, 2024 /PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies to achieve a functional cure for chronic...
Read More Details
Finally We wish PressBee provided you with enough information of ( AusperBio Secures $73 Million in Series B Financing to Advance Functional Cure for Chronic Hepatitis B )
Also on site :
- Greece probes Azerbaijani arrested for espionage for links to Iran
- Russia ready to help Iran: Kremlin spokesman
- Music Icon's Rarely Seen Daughter, 77, Photographed in Los Angeles